6FCE
NMR ensemble of Macrocyclic Peptidomimetic Containing Constrained a,a-dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors
6FCE の概要
| エントリーDOI | 10.2210/pdb6fce/pdb |
| NMR情報 | BMRB: 34222 |
| 分子名称 | ACP-HIS-DPHE-ARG-TRP-ASP-NH2 (1 entity in total) |
| 機能のキーワード | melanocortin, peptidomimetics, amino acid, dialkylated, de novo protein |
| 由来する生物種 | synthetic construct |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 870.98 |
| 構造登録者 | Brancaccio, D.,Carotenuto, A.,Grieco, P.,Merlino, F.,Zhou, Y.,Cai, M.,Yousif, A.M.,Di Maro, S.,Novellino, E.,Hruby, V.J. (登録日: 2017-12-20, 公開日: 2018-04-25, 最終更新日: 2024-10-16) |
| 主引用文献 | Merlino, F.,Zhou, Y.,Cai, M.,Carotenuto, A.,Yousif, A.M.,Brancaccio, D.,Di Maro, S.,Zappavigna, S.,Limatola, A.,Novellino, E.,Grieco, P.,Hruby, V.J. Development of Macrocyclic Peptidomimetics Containing Constrained alpha , alpha-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors. J. Med. Chem., 61:4263-4269, 2018 Cited by PubMed Abstract: We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system. PubMed: 29660981DOI: 10.1021/acs.jmedchem.8b00488 主引用文献が同じPDBエントリー |
| 実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)
をダウンロード






